Akoya Biosciences, Inc. (AKYA) - Quick Liquidity
Akoya Biosciences (AKYA) management has effectively reduced costs, positioning the business to achieve operating profit. The company is developing a spatial biology ecosystem by integrating PhenoCycler hardware with software and reagents. The price action history on GURU.Markets, where the coefficient is 0.39, confirms its status as an industry leader. Monetization relies on the sale of platforms followed by the sale of exclusive consumables, creating strong customer lock-in.
Summary analytical data breakdowns for Akoya Biosciences (AKYA)
The ratio is calculated as the relationship between cash and accounts receivable relative to current liabilities, intentionally excluding illiquid inventory. This metric determines a business's ability to instantaneously settle urgent debts without selling goods. For Akoya Biosciences (AKYA), with its complex automated phenotyping systems, this is a critical marker of financial stability in the face of high R&D costs. Fluctuations in the quick ratio signal the risk of cash flow gaps or excessive capital stagnation.